Table 1.
Patient baseline characteristics.
| Characteristics | N = 94 |
|---|---|
| Age (years) Mean ± SD | 69.1 ± 8.9 |
| Weight (kg) Mean ± SD | 79.2 ± 18.4 |
| Body Mass (kg/m2) ± SD | 27.3 ± 6.2 |
|
Gender, n (%) Male Female |
55 (59) 39 (41) |
|
Diabetes Type, n (%) Type 1 Type 2 and other |
2 (2) 92 (98) |
|
Diagnosis of Diabetes, (years) n (%) 0–1 2–10 >10 |
11 (12) 41 (44) 42 (45) |
|
Antidiabetic Drug Class, n (%) Metformin Long-acting insulin Rapid-acting insulin DPP-4 inhibitors Glinides Sulfonylureas GLP-1 receptor agonists Acarbose |
57 (61) 36 (38) 26 (28) 19 (20) 18 (19) 17 (18) 14 (15) 1 (1) |
| Antidiabetic Treatment, n (%) | |
| Monotherapy | 45 (48) |
| Bitherapy | 24 (26) |
| Tritherapy or More | 25 (26) |
| Glycated hemoglobin (%) mean ± SD | 7.56 ± 1.74 |
|
Cancer Type N (%) Digestive Hematologic Gynecologic |
54 (57) 28 (30) 12 (13) |